A recent study found the presence of class III or IV lupus nephritis was increased in patients with higher expression of the type I IFN, assessed using an IFN bioassay (OR 5.4, p < .01) (Iwamoto et al., 2022). The gene discussed is IFNA1; the disease is lupus nephritis.